• Je něco špatně v tomto záznamu ?

Survivorship after childhood cancer: PanCare: a European Network to promote optimal long-term care

L. Hjorth, R. Haupt, R. Skinner, D. Grabow, J. Byrne, S. Karner, G. Levitt, G. Michel, H. van der Pal, E. Bárdi, JD. Beck, F. de Vathaire, S. Essig, E. Frey, S. Garwicz, M. Hawkins, Z. Jakab, M. Jankovic, B. Kazanowska, T. Kepak, L. Kremer, H....

. 2015 ; 51 (10) : 1203-11. [pub] 20150506

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031355

Survival after childhood cancer has improved substantially over recent decades. Although cancer in childhood is rare increasingly effective treatments have led to a growing number of long-term survivors. It is estimated that there are between 300,000 and 500,000 childhood cancer survivors in Europe. Such good survival prospects raise important questions relating to late effects of treatment for cancer. Research has shown that the majority will suffer adverse health outcomes and premature mortality compared with the general population. While chronic health conditions are common among childhood cancer survivors, each specific type of late effect is very rare. Long-term effects must be considered particularly when addressing complex multimodality treatments, and taking into account the interaction between aspects of treatment and genotype. The PanCare Network was set up across Europe in order to effectively answer many of these questions and thereby improve the care and quality of life of survivors. The need for a structured long-term follow-up system after childhood cancer has been recognised for some time and strategies for implementation have been developed, first nationally and then trans-nationally, across Europe. Since its first meeting in Lund in 2008, the goal of the PanCare Network has been to coordinate and implement these strategies to ensure that every European survivor of childhood and adolescent cancer receives optimal long-term care. This paper will outline the structure and work of the PanCare Network, including the results of several European surveys, the start of two EU-funded projects and interactions with relevant stakeholders and related projects.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031355
003      
CZ-PrNML
005      
20151009114340.0
007      
ta
008      
151005s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejca.2015.04.002 $2 doi
035    __
$a (PubMed)25958037
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hjorth, Lars $u Skåne University Hospital, Lund University, Lund, Sweden. Electronic address: Lars.Hjorth@med.lu.se.
245    10
$a Survivorship after childhood cancer: PanCare: a European Network to promote optimal long-term care / $c L. Hjorth, R. Haupt, R. Skinner, D. Grabow, J. Byrne, S. Karner, G. Levitt, G. Michel, H. van der Pal, E. Bárdi, JD. Beck, F. de Vathaire, S. Essig, E. Frey, S. Garwicz, M. Hawkins, Z. Jakab, M. Jankovic, B. Kazanowska, T. Kepak, L. Kremer, H. Lackner, E. Sugden, M. Terenziani, LZ. Zaletel, P. Kaatsch, . ,
520    9_
$a Survival after childhood cancer has improved substantially over recent decades. Although cancer in childhood is rare increasingly effective treatments have led to a growing number of long-term survivors. It is estimated that there are between 300,000 and 500,000 childhood cancer survivors in Europe. Such good survival prospects raise important questions relating to late effects of treatment for cancer. Research has shown that the majority will suffer adverse health outcomes and premature mortality compared with the general population. While chronic health conditions are common among childhood cancer survivors, each specific type of late effect is very rare. Long-term effects must be considered particularly when addressing complex multimodality treatments, and taking into account the interaction between aspects of treatment and genotype. The PanCare Network was set up across Europe in order to effectively answer many of these questions and thereby improve the care and quality of life of survivors. The need for a structured long-term follow-up system after childhood cancer has been recognised for some time and strategies for implementation have been developed, first nationally and then trans-nationally, across Europe. Since its first meeting in Lund in 2008, the goal of the PanCare Network has been to coordinate and implement these strategies to ensure that every European survivor of childhood and adolescent cancer receives optimal long-term care. This paper will outline the structure and work of the PanCare Network, including the results of several European surveys, the start of two EU-funded projects and interactions with relevant stakeholders and related projects.
650    _2
$a mladiství $7 D000293
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a dlouhodobá péče $7 D008134
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a nádory $x mortalita $x rehabilitace $7 D009369
650    _2
$a kvalita života $7 D011788
650    _2
$a přežívající $x statistika a číselné údaje $7 D017741
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Haupt, Riccardo $u Istituto Giannina Gaslini, Genova, Italy.
700    1_
$a Skinner, Roderick $u Great North Children's Hospital, Newcastle University, Newcastle, UK.
700    1_
$a Grabow, Desiree $u German Childhood Cancer Registry, University Medical Centre Mainz, Germany.
700    1_
$a Byrne, Julianne $u Boyne Research Institute, Drogheda, Ireland.
700    1_
$a Karner, Sabine $u Austrian Childhood Cancer Organisation, Vienna, Austria.
700    1_
$a Levitt, Gill $u Great Ormond Street Hospital NHS Foundation Trust, London, UK.
700    1_
$a Michel, Gisela $u University of Lucerne, Lucerne, Switzerland.
700    1_
$a van der Pal, Helena $u Academic Medical Centre, Amsterdam, Netherlands.
700    1_
$a Bárdi, Edit $u 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
700    1_
$a Beck, Jörn D $u Kinder und Jugendklinik, Universität Erlangen, CCC ErMN, Erlangen, Germany.
700    1_
$a de Vathaire, Florent $u Institut Gustave Roussy, Paris, France.
700    1_
$a Essig, Stefan $u Institute of Primary and Community Care, Lucerne, Switzerland.
700    1_
$a Frey, Eva $u St. Anna Children's Hospital, Vienna, Austria.
700    1_
$a Garwicz, Stanislaw $u Skåne University Hospital, Lund University, Lund, Sweden.
700    1_
$a Hawkins, Mike $u University of Birmingham, Birmingham, UK.
700    1_
$a Jakab, Zsuzsanna $u 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
700    1_
$a Jankovic, Momcilo $u Fondazione MBBM, Monza, Italy.
700    1_
$a Kazanowska, Bernarda $u Wroclaw University, Wroclaw, Poland.
700    1_
$a Kepak, Tomas $u University Hospital Brno, Brno, Czech Republic.
700    1_
$a Kremer, Leontien $u Academic Medical Centre, Amsterdam, Netherlands.
700    1_
$a Lackner, Herwig $u Medical University of Graz, Graz, Austria.
700    1_
$a Sugden, Elaine $u St Hilda's College, Oxford, UK.
700    1_
$a Terenziani, Monica $u Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Italy.
700    1_
$a Zaletel, Lorna Zadravec $u Institute of Oncology, Ljubljana, Slovenia.
700    1_
$a Kaatsch, Peter $u German Childhood Cancer Registry, University Medical Centre Mainz, Germany.
700    1_
$a ,
773    0_
$w MED00009626 $t European journal of cancer (Oxford, England 1990) $x 1879-0852 $g Roč. 51, č. 10 (2015), s. 1203-11
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25958037 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20151009114527 $b ABA008
999    __
$a ok $b bmc $g 1092231 $s 914481
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 51 $c 10 $d 1203-11 $e 20150506 $i 1879-0852 $m European journal of cancer $n Eur J Cancer $x MED00009626
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Možnosti archivace